연구

연구업적

최근 5년 연구업적 현황
연도 2023년 2022년 2021년 2020년 2019년
SCI 논문
발표편수
책임 173편 163편 184편 135편 144편
공동 120편 115편 136편 168편 167편
합계 293편 278편 320편 303편 311편
1771. Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication.
Song YS, Kim Y, Cho NY, Yang HK, Kim WH, Kang GH.
Gastric Cancer. 2016 Jan;19(1):98-106. doi: 10.1007/s10120-015-0463-6. Epub 2015 Jan 22. Link
1770. Development of Drugs and Technology for Radiation Theragnosis
Hwan-Jeong Jeonga, Byung Chul Leeb, c, Byeong-Cheol Ahnd, Keon Wook Kange
Nuclear Engineering and Technology Volume 48, Issue 3, June 2016, Pages 597–607
1769. Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.
Kim YI, Yoon HJ, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kim EE, Moon WK, Kang KW.
Clin Nucl Med. 2016 Aug;41(8):614-20. doi: 10.1097/RLU.0000000000001274. Link
1768. History and Organizations for Radiological Protection.
Kang KW.
J Korean Med Sci. 2016 Feb;31 Suppl 1:S4-5. doi: 10.3346/jkms.2016.31.S1.S4. Epub 2016 Jan 29. Link
1767. Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute.
Choi Y1, Keam B1,2, Kim TM1,2, Lee SH1,2, Kim DW1,2, Heo DS1,2.
Cancer Res Treat. 2015 Oct;47(4):555-63. doi: 10.4143/crt.2014.200. Epub 2015 Feb 16. Link
1766. The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers.
Moon HG, Kim N, Jeong S, Lee M, Moon H, Kim J, Yoo TK, Lee HB, Kim J, Noh DY, Han W.
PLoS One. 2015;10(12):e0143811. doi: 10.1371/journal.pone.0143811. Link
1765. In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients.
Yoo TK, Min JW, Kim MK, Lee E, Kim J, Lee HB, Kang YJ, Kim YG, Moon HG, Moon WK, Cho N, Noh DY, Han W.
PLoS One. 2015;10(12):e0144144. doi: 10.1371/journal.pone.0144144. Link
1764. Metformin intervention in obese non-diabetic patients with breast cancer: phase II randomized, double-blind, placebo-controlled trial.
Ko KP, Ma SH, Yang JJ, Hwang Y, Ahn C, Cho YM, Noh DY, Park BJ, Han W, Park SK.
Breast Cancer Res Treat. 2015 Sep;153(2):361-70. doi: 10.1007/s10549-015-3519-8. Epub 2015 Aug 21. Link
1763. Impact of Chemotherapy-Induced Ovarian Dysfunction on Response to Neoadjuvant Chemotherapy in Breast Cancer.
Ahn SK, Lee HB, Han W, Moon HG, You JM, Kim J, Han SW, Im SA, Kim TY, Noh DY.
Ann Surg Oncol. 2015 Dec;22 Suppl 3:391-7. doi: 10.1245/s10434-015-4806-7. Epub 2015 Aug 15. Link
1762. Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples.
Kim J, Kim S, Ko S, In YH, Moon HG, Ahn SK, Kim MK, Lee M, Hwang JH, Ju YS, Kim JI, Noh DY, Kim S, Park JH, Rhee H, Kim S, Han W.
Genes Chromosomes Cancer. 2015 Nov;54(11):681-91. doi: 10.1002/gcc.22279. Epub 2015 Jul 30. Link